Monitor pricing terms (interest rate, conversion price) to gauge dilution impact and market reception. The offering extends cash runway but adds convertible debt that could be dilutive; watch for potential insider selling or further dilution if stock trades near conversion price.
Price Chart
Executive Summary
Ocugen announced a private offering of $115M convertible senior notes due 2034 (plus $15M option), intending to use ~$32.7M to repay existing Avenue loan and the remainder for general corporate purposes. The filing also provides preliminary cash of $32.2M as of March 31, 2026. This capital raise extends runway but introduces dilution overhang.
Key Facts
- Private offering of $115M aggregate principal amount of convertible senior notes due 2034
- Initial purchaser granted 13-day option to purchase up to an additional $15M of notes
- Approximately $32.7M of net proceeds to fully repay Avenue Loan Agreement
- Preliminary cash, cash equivalents, and restricted cash of ~$32.2M as of March 31, 2026
- 338,318,899 shares of common stock outstanding as of March 31, 2026
Financial Impact
$115M gross proceeds; net of ~$32.7M debt repayment and fees, net proceeds ~$80M+; prior cash $32.2M
Risk Factors
- Potential dilution upon conversion of notes
- Uncertainty in market conditions may alter offering terms
- Conversion price and interest rate not yet determined
- Pre-revenue biotech with ongoing cash burn
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001104659-26-054866 |
| Document: tm2613474d1_ex99-1.htm | 0001104659-26-054866 |
| Document: tm2613474d1_ex99-2.htm | 0001104659-26-054866 |
| Document: 0001104659-26-054866-index-headers.html | 0001104659-26-054866 |
| Document: 0001104659-26-054866-index.html | 0001104659-26-054866 |
| Document: 0001104659-26-054866.txt | 0001104659-26-054866 |
| 8-K Data (Synthetic) | 0001104659-26-054866 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 1, 2026 4w ago | Press Release | $1.33 $1.05 | ▼ −21.05% | ▼ −22.23% | $1.02 (−22.93%) |
Jul 13, 2026 11w ago | 8-K | $1.41 $1.31 | ▼ −7.09% | ▼ −10.28% | $1.02 (−27.30%) |
Jun 11, 2026 16w ago | 8-K | $1.21 $1.47 | ▲ +21.49% | ▲ +19.71% | $1.02 (−15.29%) |
Jun 11, 2026 16w ago | Institutional Cluster | $1.22 $1.47 | ▲ +20.49% | ▲ +18.60% | $1.02 (−15.98%) |
May 5, 2026 21w ago | 8-K | $1.49 $1.34 | ▼ −10.07% | ▼ −15.02% | $1.02 (−31.21%) |
May 5, 2026 21w ago | Press Release | $1.49 $1.34 | ▼ −10.07% | ▼ −15.02% | $1.02 (−31.21%) |
May 5, 2026 21w ago | Press Release | $1.49 $1.34 | ▲ +10.07% | ▲ +15.02% | $1.02 (+31.21%) |
May 4, 2026 21w ago | 8-K | $1.49 $1.34 | ▼ −10.07% | ▼ −15.02% | $1.02 (−31.21%) |
Apr 29, 2026 22w ago | Press Release | $1.68 $1.38 | ▼ −17.86% | ▼ −23.32% | $1.02 (−38.99%) |
Mar 24, 2026 27w ago | Press Release | $1.92 $1.68 | ▼ −12.50% | ▼ −21.40% | $1.02 (−46.61%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access